Kepos Capital’s Eastman Chemical EMN Stock Holding History

Kepos Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,618	Closed	-$350K	–	339
2019 Q1	$350K	Hold	4,618	–	–	0.03%	294
2018 Q4	$338K	Hold	4,618	–	–	0.03%	303
2018 Q3	$442K	Hold	4,618	–	–	0.02%	299
2018 Q2	$462K	Hold	4,618	–	–	0.02%	286
2018 Q1	$488K	Hold	4,618	–	–	0.03%	222
2017 Q4	$428K	Buy	+4,618	New	+$420K	0.04%	170

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kepos Capital's EMN Position: Q2 2019 in Review

Kepos Capital sold out of Eastman Chemical (EMN) in Q2 2019, closing a stake of 4,618 shares — an estimated $350K sold.

Kepos Capital first reported a position in EMN in Q4 2017 and held it in 6 quarters. The position peaked at $488K in Q1 2018. 636 funds tracked by Wall St. Rank hold EMN as of Q2 2019.

Kepos Capital reported no remaining Eastman Chemical position as of Q2 2019 after selling out during the quarter.
Kepos Capital sold 4,618 Eastman Chemical shares in Q2 2019, an estimated $350K.
Kepos Capital first reported a position in Eastman Chemical in Q4 2017 and held it in 6 quarters.
Kepos Capital's Eastman Chemical position peaked at $488K in Q1 2018.
636 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2019.

Based on Kepos Capital's 13F filing for Q2 2019, filed 13 Aug 2019.